Minnesota investigates Sanofi for drug pricing
Credit: Wikipedia/Sanofi de
The state of Minnesota is investigating pharmaceutical company Sanofi for its pricing and trading practices for two diabetes treatment drugs, according to a securities filing last week.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10